Description: Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval. It also offers eCOA, a data management tool for clinical scales which supports questionnaires and issue resolutions; and provides cognitive kit for detecting fluctuations in brain health. In addition, the company provides voice analysis tools for monitoring neurological and psychiatric disorders; eConsent, a patient consent solution; and Clinpal, an application for managing patients workflows. Further, it offers AQUA, a speech analysis platform for clinical scales. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.
Home Page: www.cambridgecognition.com
Tunbridge Court
Cambridge,
CB25 9TU
United Kingdom
Phone:
44 1223 810 700
Officers
| Name | Title |
|---|---|
| Mr. Rob Baker | COO & Acting Joint MD |
| Mr. Alex Livingstone-Learmonth | Chief Commercial Officer & Acting Joint MD |
| Mr. John Hammond | Co-Founder |
| Mr. Nick Taptiklis | Head of Technology Strategy |
| Ms. Francesca Cormack Ph.D. | Chief Scientist & Member of Scientific Advisory Board |
| Mr. Simon Merritt | Marketing and Communications Director |
| Dr. Lisa Elizabeth Nolan Ph.D. | Vice President Business Development |
| Ms. Nicky Ackerley | Global HR Director |
| Prof. Trevor Robbins CBE, FBPsS, FMedSci, FRS, Ph.D. | Senior Consultant |
| Prof. Barbara Sahakian FBPsS, FMedSci | Senior Consultant |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Technology |
| GIC Sub-Industry: | Health Care Technology |
| Forward PE: | 20.284 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.3418 |
| Price-to-Sales TTM: | 1.0635 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 119 |